UK Bioindustry Association Appoints New Chair and Vice Chair of Genomics Advisory Committee

Oxford, UK – 25 January 2023 – The UK Bioindustry Association (BIA) has announced PrecisionLife CEO and Co-founder, Dr Steve Gardner, as the new Chair of the national Genomics Advisory Committee. Dr Gardner will be joined by newly appointed Vice Chair Dr Danuta Jeziorska, CEO and Co-founder of Nucleome Therapeutics.

Dr Steve Gardner CEO & Co-founder, PrecisionLife

Dr Danuta Jeziorska CEO & Co-founder, Nucleome Therapeutics

The Genomics Advisory Committee aims to influence and engage with the key strategic programmes that enable the UK to start, scale and build world-leading genomic businesses, providing a platform for discussion between genomic companies and collective input to relevant policy discussions.

Steve has over 30 years’ experience of developing and commercialising ground-breaking data science and informatics in the life sciences, healthcare, and agri-tech sectors.

In the role, Drs Gardner and Jeziorska will set the strategic direction of the committee and be a key interface between its members, the BIA board, and the UK government.

"It's an honour to Chair the BIA Genomics Advisory Committee at such an exciting and important time for genomics and techbio companies, both in the UK and on the global stage”, said Dr Gardner. “I look forward to working with Danuta, our committee members, the BIA and the broad community of UK genomics researchers on our shared vision to develop and promote the UK’s vibrant and innovative genomics ecosystem.”

Steve Bates OBE, CEO of the BIA, said: "I am pleased to welcome Dr Steve Gardner as the new Chair of the BIA’s Genomics Advisory Committee (GAC). Steve brings a wealth of talent and experience to this role and is highly respected in both the life sciences and genomics communities.

“From preventing disease through early diagnosis to offering hope to patients, genomics is now the foundation underpinning modern medicine. The UK is fast delivering the potential of genomics technologies and GAC ensures that the world-leading genomic businesses are able to start, scale and grow in the UK. Dr Gardner will lead the committee to ensure it focuses on key issues and provides expert and timely advice to relevant policy discussions with the UK government."

Companies and organisations represented on the Committee include AstraZeneca, Bayer, Eagle Genomics, Illumina, IQVIA, Johnson & Johnson, Novartis, PrecisionLife, Roche, ThermoFisher Scientific, and the Wellcome Sanger Institute.

Further information on the BIA Genomics Advisory Committee can be found at: https://www.bioindustry.org/bia-membership/advisory-committees/genomics-advisory-committee.html

About the BIA

The BIA is the trade association for innovative life sciences and biotech industry in the UK, counting more than 500 companies including start-ups, biotechs, pharma, universities, research centres and investors among its members. Its mission is to be the voice of the industry, enabling and connecting the UK ecosystem so businesses can deliver world-changing innovation.